FDA panel review triggers suspension of Grail's stock trading

FDA panel review triggers suspension of Grail's stock trading

The U. S. Food and Drug Administration’s advisory committee reviewed Grail Inc.

’s multi-cancer early-detection blood test and temporarily halted trading of the company’s shares on September 24, 2026. Earlier, on September 21, 2026, Grail’s shares jumped more than 30% after the company released briefing documents ahead of the FDA panel meeting, Investor's Business Daily reported.

अभिनेताओं

Grail Inc. Food and Drug Administration

स्थान

United States

लेख

24 सितंबर 2026
3 कुल
Why Everpure Stock Is Surging To Record Highs
Why Everpure Stock Is Surging To Record Highs

Investor's Business Daily • 24 सितं 15:18

The U.S. Food and Drug Administration’s advisory committee examined Grail's multi-cancer early detection blood test, leading to a temporary halt in trading of the company’s stock.

विश्वसनीयता 72% हेरफेर 9% मध्यस्थ
Tesla Semi Joins Parade Of New Model Showcases; Stock Falls
Tesla Semi Joins Parade Of New Model Showcases; Stock Falls

Investor's Business Daily • 24 सितं 15:12

The U.S. Food and Drug Administration’s advisory committee examined Grail's multi-cancer early detection blood test, leading to a temporary halt in trading of the company’s stock.

विश्वसनीयता 72% हेरफेर 9% मध्यस्थ
Stock Market Today: Dow Falls On Rising Treasury Yields; Nvidia Stock Slides
Stock Market Today: Dow Falls On Rising Treasury Yields; Nvidia Stock Slides

Investor's Business Daily • 24 सितं 12:04

The U.S. Food and Drug Administration’s advisory committee examined Grail's multi-cancer early detection blood test, leading to a temporary halt in trading of the company’s stock.

विश्वसनीयता 72% हेरफेर 9% मध्यस्थ
23 सितंबर 2026
1 कुल
The Holy Grail In Cancer? FDA Panel Backs Blood Tests
The Holy Grail In Cancer? FDA Panel Backs Blood Tests

Investor's Business Daily • 23 सितं 22:44

The U.S. Food and Drug Administration’s advisory committee examined Grail's multi-cancer early detection blood test, leading to a temporary halt in trading of the company’s stock.

विश्वसनीयता 72% हेरफेर 9% मध्यस्थ
22 सितंबर 2026
1 कुल
Viking Therapeutics Stock Skyrockets On Obesity Drug Data. Eli Lilly, Novo Fall.
Viking Therapeutics Stock Skyrockets On Obesity Drug Data. Eli Lilly, Novo Fall.

Investor's Business Daily • 22 सितं 11:37

Grail's stock rose more than 30% after briefing documents were released before a Food and Drug Administration panel meeting on its blood test for early cancer detection.

विश्वसनीयता 68% हेरफेर 35% मध्यस्थ
21 सितंबर 2026
1 कुल
Grail Stock Catapults 30%-Plus As FDA Mulls Cancer-Detecting Blood Test
Grail Stock Catapults 30%-Plus As FDA Mulls Cancer-Detecting Blood Test

Investor's Business Daily • 21 सितं 20:14

Grail's stock rose more than 30% after briefing documents were released before a Food and Drug Administration panel meeting on its blood test for early cancer detection.

विश्वसनीयता 68% हेरफेर 35% मध्यस्थ